FDA approval of bedaquiline--the benefit-risk balance for drug-resistant tuberculosis.
作者信息
Cox Edward, Laessig Katherine
机构信息
From the Office of Antimicrobial Products, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD.
出版信息
N Engl J Med. 2014 Aug 21;371(8):689-91. doi: 10.1056/NEJMp1314385.
PMID:25140952
Abstract
摘要
Zotero 插件